Mills, Daniel W.
Woolley, Dylan M.
Ammori, Basil J.
Chinoy, Hector
Syed, Akheel A. http://orcid.org/0000-0001-8696-7121
Article History
Received: 1 February 2024
Revised: 19 March 2024
Accepted: 20 March 2024
First Online: 25 March 2024
Declarations
:
: This work was approved as a service evaluation project by the institutional clinical audit board (2023 219). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of retrospective service evaluation study formal consent does not apply.
: Prof. Chinoy received consulting fees from PTC Therapeutics and AstraZeneca, and honoraria from UCB Pharma, GSK, Pfizer, Argenx and Galapagos. All other Authors declare that they have no conflict of interest.